At CES, Intel details its launch lineup for the new Core Ultra Series 3 processors (based on its 2nm 18A architecture) that ...
Intel launched the Core ultra Series 3 chips at CES 2026, marking sharp improvements in performance and lower power.
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, and Cellares Corp, the first ...